Press Releases & Press Mentions

Press releases
Arc Bio Awarded $1.9M SBIR Grant from NIH to Optimize its Galileo ONE Metagenomic Workflow for Cerebrospinal Fluid
Feb 20, 2022
Read More

Arc Bio working with Astrea Forensics and forensic nonprofits to evaluate novel method for extracting genomic information from degraded samples
January 13, 2022
Read More

Arc Bio Launches Galileo Pathogen Solution (GPS) Product Line, a Fully Integrated NGS-based Metagenomics Platform for Revolutionizing Pathogen Detection
May 01, 2019
Read More

Arc Bio Established to Develop NGS Tools to Revolutionize Infectious Disease Field
July 24, 2018
Read More

In the News

Evaluation of a Next-Generation Sequencing Metagenomics Assay to Detect and Quantify DNA Viruses in Plasma from Transplant Recipients
Read More

Infection Identification: Metagenomic Next-generation Sequencing vs PCR
Read More

Startups Apply Powerful Genetic Sequencing Technique to Covid-19 Battle
Read More

The Rise of Metagenomics in Infectious Disease
Read More

Next Generation Sequencing: A Disruptive Genome Analysis Technology
Read More

FierceBiotech: Illumina scientist’s startup aims to rapidly detect drug resistance in bacterial DNA
Read More

Press Contact

Naissan Hussainzada, PhD
VP of Commercial Operations
[email protected]